prostate cancer Archives - Page 63 of 64 - Sperling Prostate Center

MRI and The Magic 8 Ball

Within a few years after the blog below was posted, continued progress in multiparametric MRI (mpMRI) methods bolstered its ability to predict aggressiveness of prostate cancer (PCa) before biopsy. Technologic improvements have led to faster image acquisition and higher resolution images, in turn enhancing its predictive power. Now, to add even more predictive value... keep reading

“I Did It My Way”

One of Frank Sinatra’s most popular songs is “My Way,” and anyone who’s heard him sing it knows how he builds up to those last two syllables: myyyyyy waaay. When I chose medicine as my career path, part of what influenced me was my idealism. I wanted to help people by curing disease and easing keep reading

Quality of Life After Radical Prostatectomy

Suzanne Somers once remarked, “I appreciate health care that gets to the root cause of our symptoms and promotes wellness, rather than the one-size-fits-all drug-based approach to treating disease. I love maintaining an optimal quality of life – naturally.” Ms. Somers’ words capture what we all want: to stay healthy and preserve vitality of body, keep reading

What Happens When Prostate Biopsies Are Negative?

The annual American Urological Society meeting (AUA 2015, May 15-19) has more presentations than ever on multiparametric MRI detection of prostate cancer, MRI targeted biopsies, MRI/ultrasound fusion, and MRI-guided focal therapies. The urologic world is sitting up and taking notice as advanced imaging is changing the prostate cancer landscape. I will be sharing selected presentations keep reading

The Impact of the Recommendation Against PSA Screening

In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against routine PSA screening for otherwise healthy men. Almost immediately, prostate cancer support organizations and hundreds of clinical professionals raised an outcry. While acknowledging that the non-prostate cancer specific blood test often led to over-detection and over-treatment of indolent prostate cancer, countless lives keep reading

Let’s Speak the Same MRI Diagnostic Language

A man who is suspected of having prostate cancer, or whose cancer has been biopsy confirmed, can develop the best right treatment plan if he also has a multiparametric MRI (mpMRI) of the prostate. When his own doctor sends him to an imaging center, his scan is “read” by the center’s radiologist who writes a keep reading

MRI Before TRUS Re-Biopsy Increases Accuracy

It seems intuitive, if not obvious, that superior imaging of the prostate gives precise information to guide a biopsy needle into a cancerous tumor. The typical ultrasound imaging used by urologists in their offices is inferior to magnetic resonance imaging (MRI). Ultrasound-guided transrectal (TRUS) biopsy has a minimum 35% chance of missing cancer. If our keep reading

Would You Change Your Diet to Prevent PCa?

Do you know what causes cancer? Do you believe that diet can affect your chances of either causing or preventing prostate cancer? Would you change what you eat if you thought it could make a positive difference? I ran across an interesting small study that grew out of a larger British program called the ProDiet keep reading

How Do You Feel About Screening?

A Better Prostate Cancer Blood Test - Sperling Prostate Center

If you’re like most men age 40+, you probably get your PSA (prostate specific antigen) test when you go for a physical that includes a blood draw. You learned either from your doctor, or a health promotion, that men should get a baseline PSA at age 45 (40 if you have known risk factors) and keep reading

TRUS Biopsy: Still Trying to Solve the Riddle

Matt Mullenweg, the originator of the popular open source WordPress software, has been quoted as saying, “Whenever there’s a new form of media, we always think it’s going to replace the old thing, and it never does. We still have radio, however long after TV was introduced.” It can be just as true in medicine. keep reading

Tag: prostate cancer